Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
07/1998
07/14/1998US5780509 Compound bearing two, 2,6-diiodophenol-4-YL groups and diagnostic drug for iodine allergy
07/14/1998US5780299 Method of altering blood sugar levels using non-transformed human pancreatic cells that have been expanded in culture
07/14/1998US5780044 Biocompatible solvent, biocompatible, biodegradable thermoplastic polymer, active material; controlled drug delivery
07/14/1998US5780011 Process of making radiological contrast for gastrointestinal exploration comprising barium sulfate and sucralfate
07/14/1998US5780010 Drug delivery
07/14/1998US5780006 Peptide derived radionuclide chelators
07/14/1998US5779905 Process for the depyrogenation of injectable pharmaceutical solutions
07/09/1998WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal
07/08/1998EP0852145A2 Emulsions as contrast agents and method of use
07/08/1998EP0667959A4 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE -g(b)-AMYLOID PEPTIDE.
07/08/1998EP0398955B1 Diagnosis of retinoblastoma
07/08/1998CN1187137A Novel targeted compositions for diagnostic and therapeutic use
07/07/1998US5777195 Schizophrenia, drug abuse, parkinson's, hypertension
07/07/1998US5777194 Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation
07/07/1998US5777193 Animals with targeted gene disruption
07/07/1998US5776496 Contrast agent
07/07/1998US5776429 Method of preparing gas-filled microspheres using a lyophilized lipids
07/07/1998US5776427 Methods for targeting the vasculature of solid tumors
07/07/1998US5776095 Pretargeting noncanerous cells or tissues with a cytoprotective agents before therapy with radiation or anticarcinogenic agents
07/07/1998US5776094 Method and kit for imaging and treating organs and tissues
07/07/1998US5776093 Method for imaging and treating organs and tissues
07/02/1998WO1998028336A1 Polysaccharide-peptide derivatives
07/02/1998WO1998028258A1 Compositions for increasing the mri contrast in visualising the digestive tract of patients
07/02/1998WO1998027889A1 Radiopaque solution for visualizing dental anatomy, pathological conditions, and iatrogenic events, and method of use
07/02/1998CA2275483A1 Polysaccharide-peptide derivatives
07/02/1998CA2274504A1 Radiopaque solution for visualizing dental anatomy, pathological conditions, and iatrogenic events, and method of use
07/01/1998EP0850262A1 Selectively functionalizable desdendrimers
07/01/1998EP0660724B1 Improvements in or relating to contrast agents
07/01/1998CN1186518A Human vascular endothelial growth factor 2
07/01/1998CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules
07/01/1998CN1186420A Methods and apparatus for performing diagnostis and therapeutic ultrasound simultaneously
07/01/1998CN1186419A Apparatus and method for making gas-filled vesicles of optimal size
07/01/1998CN1038940C Polymers containing biologically degradable fractured lipophilic side chains
06/1998
06/30/1998US5773292 Ablate or kill cancer cells
06/30/1998US5773231 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
06/30/1998US5773209 Prevention of formation of oxidized polyunsaturated fatty acid, suppression of gene expression through redox sensitive pathways
06/30/1998US5773024 Liposomes
06/30/1998US5773010 Low molecular weight allergen obtained from Dermatophagoides farinae
06/30/1998US5772984 Forming microbubbles of gases in carriers
06/30/1998US5772983 Methods of screening for compounds which modulate insect behavior
06/30/1998US5772982 Method of using hyaluronic acid for the detection, location and diagnosis of tumors
06/30/1998US5772651 Container for diagnostic contrast compositions
06/30/1998US5772593 Surgical operation aiding system
06/25/1998WO1998026804A1 Bioassay for compounds that prevent diabetic complications and agents identified thereby
06/25/1998WO1998017324A3 Improvements in or relating to contrast agents
06/25/1998DE19653289A1 Shaped foam body containing X=ray contrast agent
06/24/1998EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
06/24/1998EP0166755B2 Diagnostic and contrast agent
06/24/1998CN1185744A Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound
06/24/1998CN1185743A Preparation for disgnostic of the metabolic syndrome and diseases including the syndrome
06/23/1998US5770606 Administering apomorphine
06/23/1998US5770444 Growth differentiation factor-6
06/23/1998US5770384 Method for determining compound interaction with E2 binding proteins
06/23/1998US5770222 Therapeutic drug delivery systems
06/23/1998US5770181 Useful for magnetic resonance imaging and tomogrphy; consists of perfluorocarbon contrast agent, bicarbonate gas generating agent, flavor enhancing agent, a drug and a bioactive agent
06/23/1998US5770180 Bridge-substituted tropanes for methods of imaging and therapy
06/23/1998US5769937 High-purity ferromagnetic iron oxide pigments
06/23/1998US5769787 Medical scanning and treatment system and method
06/23/1998US5769088 Process and kits for diagnosing erectile dysfunction, and related methods of treatment
06/23/1998US5769080 Gas filled liposomes and stabilized gas bubbles and their use as ultrasonic contrast agents
06/23/1998CA1339927C Wavelength-specific cytotoxic agents
06/18/1998WO1998025648A2 Use of a texaphyrin in ocular diagnosis and therapy
06/18/1998WO1998018919A3 GABAa Receptor subunit epsilon-related protein
06/18/1998WO1998010797A3 Marker compositions
06/18/1998WO1998005364A3 Improvements in or relating to contrast agents
06/18/1998WO1998000535A3 Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection
06/18/1998CA2278937A1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
06/17/1998EP0847240A1 Novel embolizing compositions
06/17/1998EP0773936B1 Macrocyclic chelants, their chelates and uses thereof in the diagnostic field
06/16/1998US5767299 Triglyceride containing triiodinated phenyl group
06/16/1998US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
06/16/1998US5766572 Water-soluble carboxypolysaccharide-magnetic iron oxide complex having a small particle diameter
06/16/1998US5765562 In a sample
06/11/1998WO1998024775A1 Method for producing metal complex carboxylic acid amides
06/11/1998WO1998024774A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
06/11/1998WO1998024757A1 A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives
06/11/1998WO1998024755A1 Process for the purification of an aminoalcohol
06/11/1998WO1998024398A1 Bone cement and method of preparation
06/11/1998CA2284925A1 Bone cement and method of preparation
06/11/1998CA2244884A1 A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives
06/10/1998EP0846003A1 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
06/10/1998DE19652387A1 Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung Macrocyclic metal complex carboxylic acids, their use and processes for their preparation
06/10/1998DE19652386A1 Verfahren zur Herstellung von Metallkomplexcarbonsäureamiden A process for preparing Metallkomplexcarbonsäureamiden
06/09/1998US5763740 Method of detecting prions in a sample and transgenic animal used for same
06/09/1998US5763189 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
06/09/1998US5763172 Incubating a solution of targeted intracellular rna with a metallotexaphyrin-oligonucleotide conjugate having catalytic activity and complementary binding affinity to the target
06/09/1998US5762910 Liposoluble compounds useful as magnetic resonance imaging agents
06/09/1998US5762909 Combining active material with carrier, introducing into blood vessel
06/09/1998US5762065 Method of magnetic resonance arteriography using contrast agents
06/04/1998WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998WO1998023298A1 Perfluorinated-ether compositions as diagnostic contrast agents
06/04/1998WO1998023297A2 Particulate compositions
06/04/1998WO1998023296A1 Process for the production of iodinated organic x-ray contrast agents
06/04/1998WO1998023295A1 Method of imaging
06/04/1998WO1998023293A1 Contrast compound, contrast medium for mri, and method for mri
06/04/1998WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2272296A1 Process for the production of iodinated organic x-ray contrast agents
06/04/1998CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2271689A1 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/03/1998EP0844891A1 Hyper comb-branched polymer conjugates
1 ... 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 ... 354